INK4a/ARFLocus Alterations in Human Non-Hodgkin's Lymphomas Mainly Occur in Tumors with Wild-Type p53 Gene
- 30 June 2000
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 156 (6), 1987-1996
- https://doi.org/10.1016/s0002-9440(10)65071-7
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Aberrations of the p53 pathway components p53, MDM2 and CDKN2A appear independent in diffuse large B cell lymphomaLeukemia, 1999
- Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53The EMBO Journal, 1999
- Inactivations of p16INK4a-α, p16INK4a-β and p15INK4b genes in 2′, 3′-dideoxycytidine- and 1,3-butadiene-induced murine lymphomasOncogene, 1998
- The human protein p19ARF is not detected in hemopoietic human cell lines that abundantly express the alternative β transcript of the p16INK4a/MTS1 geneOncogene, 1997
- Genetic alterations in leukemias and lymphomas: Impressive progress and continuing complexityCancer Genetics and Cytogenetics, 1997
- Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16 INK4a but not by the alternative reading frame protein p19 ARFProceedings of the National Academy of Sciences, 1997
- Role of the INK4a Locus in Tumor Suppression and Cell MortalityCell, 1996
- Alterations of multiple tumor suppressor genes (p53 (17p13), p16INK4 (9p21), and DBM (13q14)) in B‐CELL chronic lymphocytic leukemiaMolecular Carcinogenesis, 1995
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993
- Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumoursNature, 1992